See more : BN HOLDINGS LIMITED (BNHOLDINGS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of National HealthCare Corporation (NHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National HealthCare Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Jiangxi Sunshine Dairy Co., Ltd. (001318.SZ) Income Statement Analysis – Financial Results
- Crescera Capital Acquisition Corp. (CREEF) Income Statement Analysis – Financial Results
- Beijing SDL Technology Co.,Ltd. (002658.SZ) Income Statement Analysis – Financial Results
- Land Securities Group plc (LDSCY) Income Statement Analysis – Financial Results
- GEE Group, Inc. (JOB) Income Statement Analysis – Financial Results
National HealthCare Corporation (NHC)
About National HealthCare Corporation
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.14B | 1.07B | 1.01B | 980.71M | 996.38M | 980.35M | 963.90M | 923.58M | 906.62M | 871.68M | 788.96M | 761.00M | 773.24M | 720.65M | 668.22M | 633.21M | 598.03M | 562.96M | 542.38M | 521.83M | 472.86M | 458.25M | 419.97M | 462.42M | 440.15M | 441.20M | 463.48M | 386.30M | 349.40M | 298.90M | 269.90M | 216.40M | 184.60M |
Cost of Revenue | 712.34M | 686.17M | 666.06M | 609.31M | 592.83M | 582.72M | 572.04M | 548.01M | 532.74M | 510.25M | 453.56M | 426.93M | 428.67M | 400.27M | 558.85M | 538.51M | 502.09M | 157.66M | 150.16M | 149.56M | 129.72M | 127.05M | 111.72M | 119.59M | 121.35M | 163.50M | 140.00M | 123.30M | 107.00M | 98.80M | 80.20M | 72.90M | 146.10M |
Gross Profit | 429.20M | 388.11M | 344.88M | 371.41M | 403.55M | 397.63M | 391.85M | 375.57M | 373.89M | 361.43M | 335.40M | 334.07M | 344.57M | 320.38M | 109.37M | 94.70M | 95.94M | 405.29M | 392.22M | 372.27M | 343.15M | 331.21M | 308.25M | 342.83M | 318.80M | 277.70M | 323.48M | 263.00M | 242.40M | 200.10M | 189.70M | 143.50M | 38.50M |
Gross Profit Ratio | 37.60% | 71.37% | 37.71% | 37.87% | 40.50% | 40.56% | 40.84% | 40.86% | 41.24% | 41.46% | 42.51% | 43.92% | 74.35% | 16.52% | 16.37% | 17.02% | 16.04% | 71.99% | 72.31% | 71.34% | 72.57% | 72.28% | 73.40% | 74.14% | 72.43% | 62.94% | 69.80% | 67.66% | 69.06% | 66.95% | 70.29% | 66.31% | 20.86% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 41.53M | 40.98M | 40.82M | 40.49M | 40.52M | 40.92M | 40.37M | 41.29M | 39.97M | 39.73M | 39.45M | 39.36M | 39.74M | 38.09M | 32.35M | 31.45M | 40.21M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 41.53M | 40.98M | 40.82M | 40.49M | 40.52M | 40.92M | 40.37M | 41.29M | 39.97M | 39.73M | 39.45M | 39.36M | 39.74M | 38.09M | 32.35M | 31.45M | 40.21M | 343.17M | 327.54M | 317.15M | 295.40M | 279.95M | 268.20M | 304.35M | 289.02M | 243.30M | 258.30M | 209.60M | 189.00M | 157.70M | 128.50M | 111.00M | 0.00 |
Other Expenses | 330.54M | 315.24M | 253.14M | 282.76M | 314.00M | 300.63M | 297.38M | 273.74M | 266.79M | 253.69M | 223.87M | 226.48M | 225.98M | 224.67M | 26.15M | 25.69M | 17.01M | 14.17M | 15.46M | 13.77M | 12.38M | 12.37M | 12.73M | 14.44M | 10.39M | 12.10M | 15.00M | 13.20M | 15.40M | 13.60M | 12.00M | 10.40M | 7.60M |
Operating Expenses | 372.07M | 356.22M | 293.95M | 323.25M | 354.51M | 341.55M | 337.74M | 315.03M | 306.76M | 293.42M | 263.32M | 265.83M | 265.72M | 262.76M | 58.50M | 57.14M | 57.21M | 357.34M | 343.00M | 330.91M | 307.78M | 292.32M | 280.93M | 318.79M | 299.41M | 255.40M | 273.30M | 222.80M | 204.40M | 171.30M | 140.50M | 121.40M | 7.60M |
Cost & Expenses | 1.08B | 1.04B | 960.02M | 932.56M | 947.35M | 924.27M | 909.79M | 863.04M | 839.50M | 803.67M | 716.88M | 692.77M | 694.39M | 663.03M | 617.35M | 595.66M | 559.31M | 515.01M | 493.16M | 480.48M | 437.50M | 419.36M | 392.65M | 438.38M | 420.76M | 418.90M | 413.30M | 346.10M | 311.40M | 270.10M | 220.70M | 194.30M | 153.70M |
Interest Income | 8.38M | 5.13M | 4.67M | 5.80M | 7.19M | 7.18M | 6.17M | 5.48M | 5.49M | 4.55M | 5.24M | 4.62M | 4.98M | 5.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 324.00K | 563.00K | 845.00K | 1.40M | 3.14M | 4.70M | 4.89M | 3.94M | 2.61M | 2.17M | 331.00K | 455.00K | 443.00K | 513.00K | 716.00K | 873.00K | 1.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 42.03M | 40.49M | 40.67M | 42.02M | 42.42M | 41.89M | 42.65M | 39.02M | 37.11M | 34.38M | 28.55M | 29.79M | 28.90M | 27.14M | 25.43M | 24.82M | 17.01M | 12.71M | 14.15M | 12.44M | 11.21M | 11.15M | 11.87M | 14.44M | 10.39M | 12.10M | 15.00M | 13.20M | 15.40M | 13.60M | 12.00M | 10.40M | 7.60M |
EBITDA | 131.10M | 68.28M | 191.56M | 95.84M | 133.57M | 121.48M | 122.09M | 123.17M | 125.00M | 121.74M | 131.05M | 123.73M | 128.73M | 108.62M | 93.80M | 78.98M | 90.41M | 62.12M | 64.68M | 55.12M | 47.75M | 51.26M | 40.05M | 38.48M | 29.77M | 34.40M | 65.18M | 53.40M | 53.40M | 42.40M | 61.20M | 32.50M | 38.50M |
EBITDA Ratio | 11.48% | 6.97% | 11.72% | 12.22% | 12.18% | 12.27% | 12.63% | 13.29% | 13.79% | 13.97% | 15.95% | 15.96% | 13.79% | 11.92% | 11.53% | 12.17% | 3.52% | 9.74% | 12.11% | 10.56% | -0.50% | 1.83% | -0.37% | 8.32% | 6.76% | 14.14% | 14.07% | 13.74% | 15.21% | 14.19% | 22.68% | 15.02% | 20.86% |
Operating Income | 57.13M | 31.90M | 50.93M | 48.16M | 49.04M | 56.08M | 54.11M | 60.54M | 67.13M | 68.01M | 72.08M | 68.24M | 78.85M | 57.63M | 50.87M | 37.55M | 38.73M | 47.95M | 49.22M | 41.35M | 35.37M | 38.89M | 27.32M | 24.04M | 19.39M | 22.30M | 50.18M | 40.20M | 38.00M | 28.80M | 49.20M | 22.10M | 30.90M |
Operating Income Ratio | 5.00% | 2.97% | 7.69% | 7.93% | 7.92% | 5.72% | 5.60% | 6.53% | 7.40% | 7.80% | 9.14% | 8.67% | 10.00% | 8.05% | 7.61% | 8.35% | 6.48% | 8.52% | 9.07% | 7.92% | 7.48% | 8.49% | 6.51% | 5.20% | 4.40% | 5.05% | 10.85% | 10.34% | 10.83% | 9.64% | 18.23% | 10.21% | 16.74% |
Total Other Income/Expenses | 31.60M | -4.67M | 99.11M | 4.27M | 38.98M | 18.81M | 20.44M | 19.67M | 18.15M | 17.18M | 30.10M | 25.25M | 20.53M | 23.34M | 16.78M | 15.74M | 33.51M | 6.33M | -2.53M | -1.30M | -2.08M | -11.44M | -5.16M | -6.88M | -5.35M | -32.40M | -12.98M | -40.20M | -38.00M | -28.80M | -49.20M | -22.10M | -30.90M |
Income Before Tax | 88.74M | 27.23M | 150.04M | 52.42M | 88.02M | 74.88M | 74.55M | 80.21M | 85.27M | 85.19M | 102.18M | 93.48M | 99.38M | 80.97M | 67.66M | 53.29M | 72.23M | 54.28M | 46.69M | 40.06M | 33.29M | 27.45M | 22.16M | 17.16M | 14.04M | -10.10M | 37.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 7.77% | 2.53% | 14.84% | 5.35% | 8.83% | 7.64% | 7.71% | 8.66% | 9.41% | 9.77% | 12.95% | 11.99% | 12.65% | 11.32% | 10.12% | 8.21% | 12.08% | 9.64% | 8.61% | 7.68% | 7.04% | 5.99% | 5.28% | 3.71% | 3.19% | -2.29% | 8.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 23.45M | 7.25M | 10.95M | 10.43M | 20.04M | 16.19M | 18.87M | 29.67M | 32.13M | 31.82M | 37.56M | 34.18M | 34.39M | 28.27M | 27.61M | 16.92M | 26.79M | 17.54M | 18.06M | 16.08M | 13.34M | 11.01M | 8.96M | 6.94M | 5.65M | -3.70M | 200.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 66.80M | 22.45M | 138.59M | 41.87M | 68.21M | 58.96M | 56.21M | 50.54M | 53.14M | 53.37M | 64.61M | 59.30M | 64.99M | 52.70M | 40.05M | 36.37M | 45.45M | 36.74M | 28.64M | 23.97M | 19.95M | 16.44M | 13.20M | 10.22M | 8.38M | -6.40M | 37.00M | 29.30M | 21.10M | 15.90M | 37.60M | 9.50M | 17.70M |
Net Income Ratio | 5.85% | 2.09% | 13.71% | 4.27% | 6.85% | 6.01% | 5.81% | 5.45% | 5.86% | 6.12% | 8.19% | 7.61% | 8.28% | 7.36% | 5.99% | 5.60% | 7.60% | 6.53% | 5.28% | 4.59% | 4.22% | 3.59% | 3.14% | 2.21% | 1.90% | -1.45% | 7.98% | 7.54% | 6.01% | 5.32% | 13.93% | 4.39% | 9.59% |
EPS | 4.36 | 1.46 | 9.03 | 2.74 | 4.47 | 3.87 | 3.70 | 3.34 | 3.34 | 3.24 | 4.05 | 3.65 | 4.09 | 3.22 | 2.31 | 2.16 | 3.47 | 2.99 | 0.34 | 2.05 | 1.72 | 1.43 | 1.17 | 0.89 | 0.73 | -0.58 | 4.17 | 3.48 | 2.67 | 2.02 | 4.85 | 1.28 | 2.45 |
EPS Diluted | 4.34 | 1.45 | 8.99 | 2.72 | 4.44 | 3.87 | 3.69 | 3.32 | 3.20 | 3.14 | 3.87 | 3.57 | 3.96 | 3.22 | 2.31 | 2.11 | 3.36 | 2.85 | 0.24 | 1.95 | 1.65 | 1.37 | 1.13 | 0.89 | 0.73 | -0.58 | 3.58 | 2.97 | 2.32 | 1.80 | 4.05 | 1.23 | 2.45 |
Weighted Avg Shares Out | 15.31M | 15.41M | 15.35M | 15.31M | 15.27M | 15.22M | 15.19M | 15.13M | 13.89M | 13.82M | 13.83M | 13.85M | 13.77M | 13.67M | 13.56M | 12.83M | 12.56M | 12.29M | 12.24M | 11.69M | 11.61M | 11.51M | 11.27M | 11.45M | 11.42M | 11.12M | 8.87M | 8.42M | 7.90M | 7.87M | 7.75M | 7.42M | 7.22M |
Weighted Avg Shares Out (Dil) | 15.38M | 15.45M | 15.42M | 15.37M | 15.36M | 15.24M | 15.22M | 15.21M | 14.49M | 14.22M | 16.70M | 16.60M | 16.41M | 13.68M | 13.58M | 13.13M | 12.99M | 12.89M | 12.79M | 12.29M | 12.06M | 11.97M | 11.68M | 11.47M | 11.42M | 11.12M | 10.34M | 9.87M | 9.09M | 8.83M | 9.28M | 7.72M | 7.22M |
NHC Reports Third Quarter 2024 Earnings
NHC Announces Common Dividend
NHC Reports Second Quarter 2024 Earnings
NHC Completes Acquisition of White Oak Senior Living Portfolio
Powerful Hurricane Beryl pummels Caribbean islands
Caribbean braces as Beryl strengthens to ‘extremely dangerous’ Category 4 hurricane
Hurricane Beryl, first of 2024 season, bears down on Caribbean
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of National HealthCare Corporation (NYSE:NHC) and Encourages Investors to Contact the Firm
NHC to Acquire White Oak Senior Living Portfolio
Karmanos Welcomes Wasif Saif, M.D., to Lead Phase 1 Clinical Trials
Source: https://incomestatements.info
Category: Stock Reports